Stock News
“Attention Shareholders: Don’t Miss Out on This Deadline! Levi and Korsinsky Have Got Your Back”
Welcome to the Crazy World of Stock Market Losses What to Do If You’ve Suffered a Loss on Your AstraZeneca PLC Investment Hey there, fellow investor! Have you recently experienced a loss on your AstraZeneca PLC (NASDAQ:AZN) investment? Don’t worry, you’re not alone. Many of us have been there, done that, and survived to tell…
“Secure Your Financial Future: Invest in This Index Fund for Decades of Passive Income!”
Dividends: More than Just Income for Retirees Dispelling the Myths Dividends can get a bad rap. Some assume they are for retirees who need the income to pay their bills. While it is true that dividends are a source of passive income for many retirees, they serve a much broader purpose in the world of…
“The Top Oil Stocks to Invest in with $200: A Smart Choice for 2025”
Oil Volatility in Stock Market Understanding Oil as a Commodity Oil is a crucial commodity that drives various industries across the globe. It is used for transportation, manufacturing, and energy production, making it a significant component of the global economy. However, one of the key characteristics of oil is its volatility. The prices of oil…
“Ready for Takeoff: Why Boeing Stock Could Soar Before January 28th”
Exciting Times Ahead for Boeing as Fourth-Quarter 2024 Earnings Release Approaches What to Expect Boeing (BA -1.37%) is gearing up to announce its fourth-quarter 2024 earnings on Jan. 28, and investors are on the edge of their seats waiting to hear the latest updates. With CEO Kelly Ortberg at the helm since his appointment in…
“Attention Shareholders: Important Reminder from Pomerantz Law Firm Regarding LO Stock”
Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc. New York City, NY / ACCESS Newswire / January 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ:KYTX). Investors who have purchased shares of Kyverna Therapeutics, Inc. are advised to contact Danielle Peyton…
Shareholder Alert: Pomerantz Law Firm Investigates Claims on Behalf of Business and Professional Services
Charmingly eccentric, full of personality, and designed for maximum reader engagement NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 Pomerantz LLP is investigating claims on behalf of investors of IGM Biosciences, Inc. (“IGM” or the “Company”) (NASDAQ:IGMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. The Intriguing…
“Breaking News: Pomerantz Law Firm Launches Investigation into Shareholder Claims”
Welcome To Our Blog Post Investigation into 4D Molecular Therapeutics, Inc. New York, NY / ACCESS Newswire / January 26, 2025 / Pomerantz LLP is currently conducting an investigation on behalf of investors of 4D Molecular Therapeutics, Inc. (“4D” or the “Company”) (NASDAQ:FDMT). If you are one of these investors, we advise you to reach…
“Top 3 Cyclical Stocks to Add to Your Portfolio for 2025: A Must-Read for Investors”
Introduction In last week’s Sunday Digest, I (Tom Yeung) wrote how cyclical companies are often incredible investments. Firms like copper miner Freeport–McMoRan Inc. ( FCX ) usually trade in a predetermined range (much like high and low tides at a beach), and so investors simply need to learn that range and the pattern the stock…